http:// www.prnewswire.c om/ news-releases/ anixa-bioscience s-announces-iss uance-and-publi cation-of-europ ean-patent-for- ovarian-cancer- vaccine-technol ogy-301246332.h tml?tc=eml_clea rtime
"ANIX. Their breast cancer vaccine, under development with the Cleveland Clinic, will either prove effective or not. If not — a definite possibility — our $4 or $5 may be lost. But if it does prove effective — not to mention other irons in their fire, like this one — we could see a 20-fold jump...
http:// www.prnewswire.c om/ news-releases/ anixa-bioscience s-to-participat e-in-m-vest-llc -and-maxim-grou p-llc-inaugural -emerging-growt h-virtual-confe rence-301241879 .html?tc=eml_cl eartime
"As the virus continues to adapt to humanity, it’s possible that a new variant will arise that can render the current vaccines largely or completely ineffective." Dr. Amit Kumar, CEO Anixa Biosciences.
“The data is compelling enough to give us great hope of eliminating this most common malignancy in women. Hence the… https://t.co/ExF9WT6w2W
"We are working on developing, along with the Cleveland Clinic, a vaccine for ovarian cancer. This vaccine utilize… https://t.co/bAagkxQOub
"It is always the case that preventing a disease is better than treating a disease once it arises." Dr Amit Kumar,… https://t.co/7mh2aobrtX
5 Myths About The COVID-19 Vaccine, Debunked https://t.co/klDNELy41u via @sheknows @AnixaBio
Learn more: https://t.co/1fqchb2d3a https://t.co/9Gt5IVaExJ
Feds release all reserved COVID-19 vaccine doses https://t.co/U5IWbZ3Ptu via @nypost
Similar Businesses
